International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2021
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.
СтатьяПоддержка исследования: вне правительства СШАОбзорConsensus StatementНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sundar Sudha, Manchanda Ranjit, Gourley Charlie, George Angela, Wallace Andrew, Balega Janos, Williams Sarah, Wallis Yvonne, Edmondson Richard, Nicum Shibani, Frost Jonathan, Attygalle Ayoma, Fotopoulou Christina, Bowen Rebecca, Bell Dani, Gajjar Ketankumar, Ramsay Bruce, Wood Nicholas J, Ghaem-Maghami Sadaf, Miles Tracie, Ganesan Raji
Аннотация
The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group comprising experts in surgical gynecological oncology, medical oncology, genetics, and laboratory science, and clinical nurse specialists to identify the optimal pathways to BRCA germline and tumor testing in patients with ovarian cancer in routine clinical practice. In particular, the group explored models of consent, quality standards identified at pathology laboratories, and experience and data from pioneering cancer centers. The group liaised with representatives from ovarian cancer charities to also identify patient perspectives that would be important to implementation. Recommendations from these consensus group deliberations are presented in this manuscript.